Zusammenfassung
Störungen der zellulären Hämostase gehören zu den häufigsten Hämostasestörungen in der Klinik. Das bedeutet, daß beim Ausschluß eines perioperativen Blutungsrisikos keineswegs nur Störungen der plasmatischen Gerinnung und Fibrinolyse sondern ebenso Störungen der zellulären Hämostase zu beachten sind. Da hereditäre Störungen sowohl der plasmatischen wie der zellulären Hämostase selten sind, stehen erworbene und allen voran medikamentöse Wirkungen im Vordergrund.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alshameeri RS, Mammen EF (1995) Clinical experience with the Thrombostat 4000. Sem Thromb Hemost 21 (S2): 1–10
Coller BS, Anderson K, Weisman HF (1995) New antiplatelet agents: Platelet GPIIb/IIIa antagonists, Thromb Haemost 74: 302–308
De Caterina R, Lanza M, Strata GB, Maffei S, Salvatore L (1994) Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 84: 3363–3370
Edmunds LH, Salzman EW (1994) Hemostatic problems, transfusion therapy, and cardiopulmonary bypass in surgical patients. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and thrombosis: basic principles and clinical practice, 3rd edn. Lippincott, Philadelphia, pp 956–968
Ferraris VA, Swanson E (1983) Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obst 156: 439–445
Harker LA, Hanson SR, Kelly AB (1995) Antithrombotic benefits and hemorrhagic risks of direkt thrombin antagonists. Thromb Haemost 74: 464–472
Hass WK, Easton JD, Adams HP et al. (1989) A randomized trial comparing triclopidin hydrochloride with aspirin for the prevention of stroke in high-risk patients N Engl J Med 321: 501–507
Kratzer MAA, Born GVR (1985) Simulation of primary hemostasis in vitro. Haemostasis 15: 357–362
Lind SE (1991) The bleeding time does not predict surgical bleeding. Blood 77: 2547–2552
Reilly IAG, Fitz Gerald GA (1987) Inhibition of thromboxane formation in vivo and ex vivo: Implications for therapy with platelet inhibitory drugs. Blood 69: 180–186
Ulshöfer B, Dorst V, Kretschmer V, Köhl H, Riedmiller H (1995) Hemostaseological management of urological operations in patients taking aspirin using the Thrombostat 4000. Sem Thromb Hemost 21 (S2): 52–58
Weissmann G (1991) Aspirin: alte and neue Erkenntnisse. Spektrum Wiss März: 118–126
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Patscheke, H. (1997). Perioperatives Blutungsrisiko bei Einnahme von Aggregationshemmern und NSAR. In: Martin, E., Nawroth, P. (eds) Fachübergreifende Aspekte der Hämostaseologie II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60626-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-60626-7_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61946-8
Online ISBN: 978-3-642-60626-7
eBook Packages: Springer Book Archive